Regeneron Pharmaceuticals Inc (NASDAQ:REGN) under-valued by 11%
| Website | https://www.regeneron.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $61,348,819,000 |
| Beta | 0.39922 |
| Average Volume | $872,232 |
| Last Dividend | 0% |
| Price on Aug 5, 2020 | $583.14 |
| Autochartist™ Valuation | $644.81 |
| Conclusion |
11% under-valued |
| Download Report |
